Home / Research and experimental development on biotechnology (except medical and veterinary science)

MINGYUAN SHENGKE HOLDINGS PTE. LTD.

Live CompanyUEN 202445238MLocal Company

MINGYUAN SHENGKE HOLDINGS PTE. LTD. is a local company in Singapore with UEN 202445238M. It was registered on 4 Nov 2024, 1 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202445238M
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered4 Nov 2024
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity85509 Training courses n.e.c.
Address2 LENG KEE ROAD, #04-10A, THYE HONG CENTRE, Singapore 159086
300 companies at this address
AreaBukit Merah · District 3 (Queenstown, Tiong Bahru)
Nearest stationRedhill MRT, about 304 m
Officers2
Last annual return28 May 2026

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.